Accessibility Menu
Twinlab Consolidated logo

Twinlab Consolidated(OTC) TLCC

Market Cap$103.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2015)-100%
5 Year-100%
1 Year+33%
1 Month-33%
$0.00
+0%
+0.00Today
Twinlab Consolidated last closing stock price
MetricPriceDate
Last closeUSD 0.002026-02-04
Twinlab Consolidated stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-33.33%USD 0.002025-10-16
1 month-33.33%USD 0.002025-10-16
3 month-33.33%USD 0.002025-10-16
Year to date-33.33%USD 0.002025-10-16
1 year+33.33%USD 0.002025-01-23
3 year-99.6%USD 0.102023-01-18
5 year-99.91%USD 0.442021-02-05
Since inception-99.96%USD 1.102015-05-07

Twinlab Consolidated Financials at a Glance

Market Cap

$103.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$11.35M

Net Income (TTM)

-$7.90M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.09 (Low)

Price

$0.00

Volume

100,899

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Aug 4, 2025

TLCC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Twinlab Consolidated

Twinlab makes vitamins, supplements, and herbal teas for everyday health needs. Its products help people seeking better nutrition or specific wellness goals. Shoppers find these items in stores or online for daily use.

What’s on the Shelf? Twinlab’s Main Offerings

  • Vitamins and Minerals: Daily supplements for general health, targeting adults and seniors.
  • Specialty Supplements: Products like collagen and resveratrol for skin, joint, and aging support.
  • Sports Nutrition: Powders and capsules for athletes and fitness enthusiasts.
  • Diet and Energy: Supplements for weight management and energy, mainly under the Metabolife brand.
  • Herbal Teas: Alvita teas for consumers seeking natural wellness options.

Growth Spurts and Growing Pains

  • Exited private label manufacturing (NutraScience Labs) in Q3 2023 to cut losses.
  • Reduced workforce and surrendered office leases in 2024 to lower costs.
  • Focused on core brands and profitable products since 2023.
  • Negotiated lower supplier prices and restructured debt in 2024.

Why Twinlab Stands Out (or Tries To)

Twinlab sells through health food stores, mass retailers, and online channels, reaching a broad audience. Its multi-brand approach targets different consumer needs, from sports nutrition to healthy aging. The company emphasizes product certifications and quality standards to appeal to health-conscious buyers.

Five Things You Need to Know

  • Revenue was $2M in Q3 2024, down 36.8% from Q3 2023.
  • Gross profit was $642,000 in Q3 2024, down 51.8% year-over-year.
  • Net loss was $3M in Q3 2024, 14% worse than Q3 2023.
  • Cash flow from operations was negative $327,000 in Q3 2024.
  • Top three customers made up 53% of 2024 sales, up from 32% in 2023.

Bottom Line

Twinlab has narrowed its focus to core supplement brands and cost control. The company faces ongoing financial and operational challenges as it adapts to a changing market.

AI Generated • Apr 16, 2026

Industry

Personal Products

Sector

Consumer Staples

Employees

7

CEO

Kyle Casey

Website

www.tchhome.com

Headquarters

Weston, FL 33431, US

TLCC Financials

Key Financial Metrics (TTM)

Gross Margin

36.81%

Operating Margin

-10.20%

Net Income Margin

-100.71%

Return on Equity

10.38%

Return on Capital

N/A

Return on Assets

-151.96%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$103.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

259.09M

Volume

100.90K

Avg. Volume

0

Financials (TTM)

Gross Profit

$3.72M

Operating Income

-$1.39M

EBITDA

-$925.00K

Operating Cash Flow

$2.31M

Capital Expenditure

-$941.00K

Free Cash Flow

$2.31M

Cash & ST Invst.

$14.00K

Total Debt

$95.64M

Twinlab Consolidated Performance Analysis

Twinlab Consolidated annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 72,089,000N/A
20222022-12-31USD 17,208,000-76.1%
20232023-12-31USD 13,617,000-20.9%
20242024-12-31USD 11,665,000-14.3%
Twinlab Consolidated sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-31-14.5%
Q12024-03-31-11.9%
Q22024-06-3012.6%
Q32024-09-30-25.5%
Twinlab Consolidated annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.06N/A
20222022-12-31USD -0.03-45.1%
20232023-12-31USD -0.0566.9%
20242024-12-31USD -0.04-30.6%
Twinlab Consolidated sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42023-12-3134.1%
Q12024-03-31-35.0%
Q22024-06-3024.7%
Q32024-09-30-68.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$2.32M

-36.8%

Gross Profit

$642.00K

-51.8%

Gross Margin

27.65%

N/A

Market Cap

$103.60KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$6.09K

N/A

Employees

17

N/A

Net Income

-$2.68M

-14.0%

EBITDA

-$602.00K

-159.1%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$14.00K

-72.0%

Total Debt

$95.64M

-3.6%

Accounts Receivable

$1.84M

+83.4%

Inventory

$2.76M

-37.3%

Long Term Debt

$1.46M

-47.0%

Short Term Debt

$94.18M

-3.4%

Return on Assets

-1.52%

N/A

Return on Invested Capital

1.02%

N/A

Free Cash Flow

-$327.00K

-257.2%

Operating Cash Flow

-$327.00K

-257.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
TGRRTiger Reef, Inc.
$0.00+0.00%
AVOZAltavoz Entertainment, Inc.
$0.00+0.00%
TVOGTurner Valley Oil & Gas, Inc.
$0.00+0.00%
UPDCUPD Holding Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.67-0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.25+0.10%
NOKNokia
$9.28+0.02%
AALAmerican Airlines Group
$14.95+0.03%

Questions About TLCC

What is the current price of Twinlab Consolidated?

Twinlab Consolidated is trading at $0.00 per share.

What is the 52-week range for Twinlab Consolidated?

Over the past 52 weeks, Twinlab Consolidated has traded between $0.00 and $0.00.

How much debt does Twinlab Consolidated have?

As of the most recent reporting period, Twinlab Consolidated reported total debt of $96.84M.

How much cash does Twinlab Consolidated have on hand?

Twinlab Consolidated reported $69.00K in cash and cash equivalents in its most recent financial results.

What is Twinlab Consolidated’s dividend yield?

Twinlab Consolidated does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services